Tripler Army Medical Center is a major United States Department of Defense medical facility administered by the United States Army in the state of Hawaii.

During the past decade, Tripler Army Medical Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 61 clinical trials were completed, i.e. on average, 225.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 23 clinical trials were completed. i.e. 328.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tripler Army Medical Center" #1 sponsor was "Children's Oncology Group" with 54 trials, followed by "SWOG Cancer Research Network" with 48 trials sponsored, "National Cancer Institute (NCI)" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored and "Tripler Army Medical Center" with 15 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tripler Army Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "Eastern Cooperative Oncology Group" with 6 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Tripler Army Medical Center" are "Leukemia" (20 trials), "Lung Cancer" (12 trials), "Breast Cancer" (11 trials), "Lymphoma" (9 trials) and "Sarcoma" (8 trials). Many other conditions were trialed in "Tripler Army Medical Center" in a lesser frequency.

Most popular intervention types in "Tripler Army Medical Center" are "Drug" (137 trials), "Other" (67 trials), "Biological" (46 trials), "Procedure" (37 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "cyclophosphamide" (24 trials), "etoposide" (22 trials), "radiation therapy" (21 trials) and "filgrastim" (17 trials). Other intervention names were less common.

The vast majority of trials in "Tripler Army Medical Center" are 149 trials for "All" genders, 32 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Tripler Army Medical Center". 1 are not yet recruiting, 10 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 120 completed trials in Tripler Army Medical Center, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Tripler Army Medical Center, 7 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".